Preparation and application of pH-responsive drug delivery systems
2022 · Journal of Controlled Release · 504 citations
https://doi.org/10.1016/j.jconrel.2022.05.056
P
Ping Tan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
3.2K
Citations
28
h-index
59
i10-index
Ping Tan is an academic researcher from Army Medical University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Inflammatory Biomarkers in Disease Prognosis. The author has an h-index of 28, co-authored 103 publications.
ORCID: 0000-0002-7445-3577Papers by this author
worksHeterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
2020 · EBioMedicine · 199 citations
https://doi.org/10.1016/j.ebiom.2020.102976
The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis
2016 · Scientific Reports · 36 citations
https://doi.org/10.1038/srep29106
LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies
2016 · Scientific Reports · 33 citations
https://doi.org/10.1038/srep24521
SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
2022 · Cell Death and Disease · 22 citations
https://doi.org/10.1038/s41419-022-05392-6
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression
2023 · Military Medical Research · 16 citations
https://doi.org/10.1186/s40779-023-00500-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat